Study Protocol for the Arterial Revascularisation Trial
Author Information
Author(s): David P Taggart, Belinda Lees, Alastair Gray, Douglas G Altman, Marcus Flather, Keith Channon
Primary Institution: Nuffield Dept of Surgery, University of Oxford
Hypothesis
Does bilateral internal mammary artery grafting improve survival compared to single internal mammary artery grafting in coronary revascularisation?
Conclusion
The Arterial Revascularisation Trial aims to determine if using both internal mammary arteries during CABG improves survival and reduces the need for further interventions.
Supporting Evidence
- The trial will include 3000 patients from 20 centres across the UK, Australia, Poland, and Brazil.
- The primary outcome is survival at 10 years, with secondary outcomes including quality of life and cost-effectiveness.
- The study aims to provide definitive evidence on the benefits of bilateral versus single internal mammary artery grafting.
Takeaway
This study is trying to find out if using two arteries instead of one during heart surgery helps people live longer and stay healthier.
Methodology
A two-arm, randomised multi-centre trial comparing single versus bilateral internal mammary artery grafting in 3000 patients.
Potential Biases
Potential bias in patient selection and outcomes due to the nature of surgical procedures.
Limitations
The study may face challenges in patient recruitment and follow-up due to non-compliance with questionnaires.
Participant Demographics
Patients requiring coronary artery bypass graft surgery with multi-vessel coronary artery disease.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website